(Q37024082)

English

Metabolic side effects and cardiovascular events of diuretics: should a diuretic remain the first choice therapy in hypertension treatment? The case of yes.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

Metabolic side effects and cardiovascular events of diuretics: should a diuretic remain the first choice therapy in hypertension treatment? The case of yes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

arterial hypertension

0 references

author name string

Dimitris P Papadopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Vasilios Papademetriou

2

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Clinical and Experimental Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

503-516

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Diuretics and the therapy of hypertension

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

The evolution of low-dose diuretic therapy: the lessons from clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Diuretics in hypertension: clinical experiences

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Diuretic complications

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

The efficacy and safety of diuretics in treating hypertension

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Diuretics and beta-blockers: is there a risk for dyslipidemia?

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Hyperlipidemia in hypertension: causes and prevention

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Thiazide diuretics and the initiation of anti-gout therapy

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Diuretic-induced ventricular ectopic activity

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Diuretic-induced hypokalemia in uncomplicated systemic hypertension: effect of plasma potassium correction on cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Diuretics, Serum and Intracellular Electrolyte Levels, and Ventricular Arrhythmias in Hypertensive Men

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Elevated potassium intake inhibits neointimal proliferation in the swine coronary artery

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

High K diets markedly reduce atherosclerotic cholesterol ester deposition in aortas of rats with hypercholesterolemia and hypertension

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Potassium chloride supplementation diminishes platelet reactivity in humans

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Sudden cardiac death in patients with hypertension. An association with diuretics and beta-blockers?

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Creating a combination antihypertensive regimen: what does the research show?

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

The first hypertension trial comparing the effects of two fixed-dose combination therapy regimens on cardiovascular events: Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH).

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapies

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Is the development of diabetes with antihypertensive therapy a problem?--Pro

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Old antihypertensives and new diabetes

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Thiazide diuretics, potassium, and the development of diabetes: a quantitative review

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Effect of ramipril on the incidence of diabetes

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Antihypertensive therapy and new onset diabetes

1 reference

https://api.crossref.org/works/10.1080%2F10641960701743964

21 January 2018

Identifiers

10.1080/10641960701743964

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37024082&oldid=1358426023"